Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy. uri icon

authors

  • Gomes, Bruno
  • Fantin, Valeria R
  • Letellier, Marie-Claire
  • Li, Wenlin
  • Maegley, Karen
  • Marillier, Reece
  • Miller, Nichol
  • Pirson, Romain
  • Rabolli, Virginie
  • Ray, Chad
  • Driessens, Gregory
  • Streiner, Nicole
  • Torti, Vince R
  • Tsaparikos, Konstantinos
  • Van den Eynde, Benoit J
  • Wythes, Martin
  • Yao, Li-Chin
  • Zheng, Xianxian
  • Tumang, Joseph
  • Kraus, Manfred
  • Bartlett, Derek
  • Cai, Danying
  • Cauwenberghs, Sandra
  • Crosignani, Stefano
  • Dalvie, Deepak
  • Denies, Sofie
  • Dillon, Christopher P

publication date

  • January 1, 2018